> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Web Site Selling Illegal New Drugs, FDA Says
- URL: https://www.fdaweb.com/web-site-selling-illegal-new-drugs-fda-says/
- Published: 2021-06-15T12:00:00.000Z
- Updated: 2026-09-14T17:03:21.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149543

FDA says its review of a Web site at [www.pharmacygeoff.md](http://www.pharmacygeoff.md/?ref=fdaweb.com) determined that the site is offering drug products for sale in the U.S. intended to mitigate, treat, prevent, diagnose, or cure Covid-19 and several other diseases such as lupus, rheumatoid arthritis, malaria, HIV, and hepatitis C. A just-released 4/15 [Warning Letter](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmacygeoffmd-614055-04152021?ref=fdaweb.com) says the agency has determined that the products are misbranded unapproved new drugs.

Among the products offered, the letter says, are Plaquenil (hydroxychloroquine sulfate) manufactured by Sanofi, Lariago-DS (chloroquine), and Hivus-LR (lopinavir and ritonavir).

“FDA is taking this action against [www.pharmacygeoff.md](http://www.pharmacygeoff.md/?ref=fdaweb.com) because of the inherent risk to consumers who purchase misbranded and unapproved new drugs,” the letter says. The Web site was told to respond within 48 hours with a list of specific steps taken to address the violations and prevent their recurrence, with an explanation and documentation of each step, and a timetable for completing the work.